PODD 266.57 (+3.9%)
US45784P1012Medical Devices & InstrumentsMedical Devices

Insulet (PODD) Stock Highlights

266.57 | +3.9%
2024-12-21 00:35:49
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.

Statistics

Range Today
256.56 270.7
Volume Today 1.34M
Range 1 Year
160.19 279.77
Volume 1 Year 190.68M
Range 3 Year
125.82 335.91
Volume 3 Year 551.56M
Range 10 Year
23.94 335.91
Volume 10 Year 1.57B

Highlights

Market Capitalization 18.79B (large)
Floating Shares 69.75M
Current Price 266.57
Price To Earnings 43.69
Price To Revenue 8.93
Price To Book 16.81
Earnings Per Share 5.88
Payout Ratio 0%

Performance

Latest +3.9%
1 Month +1.65%
3 Months +13.29%
6 Months +36.07%
1 Year +24.22%
3 Years +1.28%
5 Years +54.87%
10 Years +478.12%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.